Show simple document record

dc.contributor.authorRoy, Élisefr
dc.contributor.authorArruda, Nelsonfr
dc.contributor.authorBertrand, Karinefr
dc.contributor.authorDufour, Magalifr
dc.contributor.authorLaverdière, Eméliefr
dc.contributor.otherJutras-Aswad, Didierfr
dc.contributor.otherPerreault, Michelfr
dc.contributor.otherBerbiche, Djamalfr
dc.contributor.otherBruneau, Juliefr
dc.date.accessioned2018-10-01T14:09:12Z
dc.date.available2018-10-01T14:09:12Z
dc.date.created2016fr
dc.date.issued2018-10-01
dc.identifierPMID: 27397582fr
dc.identifier.urihttp://hdl.handle.net/11143/13611
dc.description.abstractAbstract: BACKGROUND: There is growing evidence of intravenous administration of prescription opioids (POs) in several countries. Preparation of POs for injection may leave residues in containers and filters used by people who inject drugs and may lead to adverse health outcomes if they are injected. METHODS: This exploratory study used cross-sectional data from the COSMO study, a prospective cohort of out-of-treatment cocaine users carried out in Montréal (Canada) between October 2010 and August 2015. For this analysis, only one visit per participant was selected, that is, the first time the participant reported PO injection during the study. The outcome of interest, "injection of PO residues", was defined as having injected PO residues from a filter and/or a container in the last month. Correlates of this outcome were identified using logistic regression analyses. RESULTS: Of the 122 participants who reported PO injection during the study period, 41.8% had injected PO residues. Reporting an unstable source of income (AOR=4.26; 95% CI: 1.03-17.69), a recent overdose (AOR=5.45; 95% CI: 1.50-19.88) and a preponderant use of opiates (mostly opiate use versus other drugs excluding alcohol and cannabis) (AOR=2.46; 95% CI: 1.08-5.63) increased the risk of PO residue injection. The odds of reporting PO residue injection rose by 7% per unit increase in the score of psychological distress (AOR=1.07 per unit increase; 95% CI: 1.01-1.12). CONCLUSIONS: The findings of this study suggest that PO residue injection is associated with markers of vulnerability. Further investigation is needed in order to better understand this understudied drug injection practice.fr
dc.language.isoengfr
dc.relation.isformatofhttps://doi.org/10.1016/j.drugalcdep.2016.06.025fr
dc.relation.ispartofISSN:1879-0046fr
dc.relation.ispartofDrug and Alcohol Dependencefr
dc.rightsAttribution - Pas d’Utilisation Commerciale - Pas de Modification 2.5 Canada*
dc.rightsAttribution - Pas d’Utilisation Commerciale - Pas de Modification 2.5 Canada*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/ca/*
dc.subjectInjection drug usefr
dc.subjectInjection risk behaviorsfr
dc.subjectDrug residue injectionfr
dc.subjectPrescription opioidsfr
dc.titlePrevalence and correlates of prescription opioid residue injectionfr
dc.typeArticlefr
udes.description.typestatusPost-publicationfr
udes.description.typepubRévisé et accepté par des pairsfr
udes.description.pages69-74fr
udes.description.period166fr
udes.description.sponsorshipInstituts de recherche en santé du Canadafr
udes.description.diffusionDiffusé par Savoirs UdeS, le dépôt institutionnel de l'Université de Sherbrookefr
dc.identifier.bibliographicCitationRoy É, Arruda N, Bertrand K, Dufour M, Laverdière E, Jutras-Aswad D, Perreault M, Berbiche D, Bruneau J. (sous presse). (2016). Prevalence and correlates of prescription opioid residue injection. Drug Alcohol Depend, 66, 69-74. https://doi.org/10.1016/j.drugalcdep.2016.06.025fr
udes.description.sourceDrug and Alcohol Dependencefr
udes.autorisation.depottruefr
udes.description.ordreauteursRoy, Élise; Arruda, Nelson; Bertrand, Karine; Dufour, Magali; Laverdière, Emélie; Jutras-Aswad, Didier; Perreault, Michel; Berbiche, Djamal; Bruneau, Juliefr


Files in this document

Thumbnail
Thumbnail

This document appears in the following Collection(s)

Show simple document record

Attribution - Pas d’Utilisation Commerciale - Pas de Modification 2.5 Canada
Except where otherwise noted, this document's license is described as Attribution - Pas d’Utilisation Commerciale - Pas de Modification 2.5 Canada